The Royal Institution for the Advancement of Learning/McGill University Patent applications |
Patent application number | Title | Published |
20160027961 | METHODS AND DEVICES FOR SOLID STATE NANOWIRE DEVICES - Solid state sources offers potential advantages including high brightness, electricity savings, long lifetime, and higher color rendering capability, when compared to incandescent and fluorescent light sources. To date however, many of these advantages, however, have not been borne out in providing white LED lamps for general lighting applications. The inventors have established that surface recombination through non-radiative processes results in highly inefficient electrical injection. Exploiting in-situ grown shells in combination with dot-in-a-wire LED structures to overcome this limitation through the effective lateral confinement offered by the shell the inventors have demonstrated core-shell dot-in-a-wire LEDs, with significantly improved electrical injection efficiency and output power, providing phosphor-free InGaN/GaN nanowire white LEDs operating with milliwatt output power and color rendering indices of 95-98. Additionally, the inventors demonstrate efficient UV nanowire LEDs for medical applications as well as the non-degraded growth of nanowire LEDs on amorphous substrates. | 01-28-2016 |
20150376214 | HETEROCYCLYL-PYRIDINYL-BASED BIPHOSPHONIC ACID, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF - The present invention relates to novel compounds, compositions containing same and methods for inhibiting human farnesyl pyrophosphate synthase or for the treatment or prevention of disease conditions using said compounds; | 12-31-2015 |
20150307532 | THIENOPYRIMIDINE INHIBITORS OF FARNESYL AND/OR GERANYLGERANYL PYROPHOSPHATE SYNTHASE - The present invention relates to novel compounds, compositions containing same and methods for inhibiting human farnesyl pyrophosphate synthase or for the treatment or prevention of disease conditions using said compounds; | 10-29-2015 |
20150231254 | POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF - The present disclosure provides a conjugate of formula (I) | 08-20-2015 |
20150143817 | METHOD AND SYSTEM FOR MAGNETIC SEMICONDUCTOR SOLID STATE COOLING - Cryogenic electronics based upon semiconductive devices, superconductive devices, or a combination of the two present opportunities for a wide variety of novel, fast, and low power devices. However, such cryogenic electronics require cooling which is typically achieved through fluid refrigerants such as liquid nitrogen or liquid helium. Solid state refrigeration based upon adiabatic demagnetization in paramagnetic salts offers one alternative but requires that the solid state cooler and cryogenic electronic circuits be different physical elements. The inventors present solid state cooling for semiconductor materials including but not limited to silicon. Beneficially active electronic devices can be integrated monolithically with solid state semiconductor coolers exhibiting magnetic cooling within the whole substrate or predetermined regions of the substrate. Alternatively, active devices may be formed with semiconductor layers integral to them that exhibit magnetic cooling. | 05-28-2015 |
20150110216 | METHODS AND DEVICES FOR COMMUNICATIONS SYSTEMS USING MULTIPLIED RATE TRANSMISSION - Cost, electronic circuitry limitations, and communication channel behaviour yield communication systems with strict bandwidth constraints. Hence, maximally utilizing available bandwidth is crucial, for example in wireless networks, to supporting ever increasing numbers of users and their demands for increased data volumes, low latency, and high download speeds. Accordingly, it would be beneficial for such networks to support variable bandwidth allocations such that smaller frequency sub-bands are allocated to users, as their number increases, but the individual users/nodes insert more data-carrying signals in order to compensate pensate for the loss of operating bandwidth arising from the accommodation of more users. It would further be beneficial for transmitters and receivers according to embodiments of such a network architecture to be based upon low cost design methodologies allowing their deployment within a wide range of applications including high volume, low cost consumer electronics for example. | 04-23-2015 |
20150087072 | SOIL ANALYSIS APPARATUS, METHOD, AND SYSTEM - A soil analysis apparatus includes at least one sensor element for measuring a property of the soil; a blade assembly having at least one blade and being displaceable between a raised position and an excavation position, the at least one blade being operable to excavate the soil at a test location when the blade assembly is in the excavation position, the blade assembly being further operable to enter a sensor permitting configuration; and a first actuator operable to displace the at least one sensor element between an initial position and a sensing position along a sensor displacement path, the sensor element being proximate the soil at the test location when in the sensing position. | 03-26-2015 |
20140378541 | Synthetic Epigallocatechin Gallate (EGCG) Analogs - Synthetic polyphenolic compounds of formula (I), their modes of synthesis, and pharmaceutical compositions thereof are provided herein. Use of the compounds and compositions described herein for treating cancer and for treating metabolic disorders is also provided. | 12-25-2014 |
20140343124 | METHOD FOR REDUCING EXPRESSION OF DOWNREGULATED IN RENAL CELL CARCINOMA IN MALIGNANT GLIOMAS - The present invention relates to novel compositions and therapeutic methods for the treatment of cancer, in particular malignant glioma. The compositions include antisense oligonucleotides or RNAs or vectors encoding them which reduce expression of downregulated in renal cell carcinoma (DRR) in tumor cells, and inhibit malignant glioma cell invasion. | 11-20-2014 |
20140329894 | COMBINATION THERAPY AND USES THEREOF FOR TREATMENT AND PREVENTION OF PARASITIC INFECTION AND DISEASE - The invention relates to compounds, methods, uses, compositions, combinations, kits and packages for the prevention and/or treatment of parasite infection (e.g., | 11-06-2014 |
20140329767 | Compositions and Methods for Preventing and Treating Diseases and Environmentally Induced Health Disorders - Nutraceutical or pharmaceutical compositions, functional foods, extracts, dietary supplements and food/feed additives enriched in phytochemicals having antioxidant and/or anti-inflammatory activity may be derived from the skin, pith, or cortex from stem tubers of select potato cultivars, such as Onaway, Russet Burbank, Purple Valley or Bora Valley cultivars. These cultivars and combinations thereof provide a useful antioxidant source enriched in ferulic acid, caffeic acid, chlorogenic acids, ascorbic acid, anthocyanins, and rutin, isomers or derivatives thereof having antioxidant and/or anti-inflammatory activity. | 11-06-2014 |
20140323535 | 5-OXO-ETE RECEPTOR ANTAGONIST COMPOUNDS - The present invention relates to novel pharmaceutically-useful compounds which are antagonists of the 5-oxo-ETE receptors, such as the OXE receptor. These compounds have use as therapeutic and/or prophylactic agents for diseases characterized by tissue eosinophilia, such as inflammatory conditions including respiratory diseases. The invention also relates to pharmaceutical compositions, to the use of such compounds and compositions as medicaments, and to therapeutic methods. | 10-30-2014 |
20140256926 | Ionic Tags for Synthesis of Oligoribonucleotides - The invention relates to the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. In another aspect, the invention relates to compounds of formula (II) processes for making these compounds, and the use thereof in the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. The invention also relates to methods of synthesis of oligomers, including but not limited to oligopeptides, oligosaccharides and oligonucleotides, particularly oligoribonucleotides and also oligodeoxyribonucleotides, in solution systems, and ionic tag linkers for use in methods provided herein. | 09-11-2014 |
20140186263 | MALEIMIDE-FUNCTIONALIZED GOLD NANOPARTICLES - A maleimide-functionalized gold nanoparticle is described herein. More specifically, a maleimide-functionalized gold nanoparticle of formula (I): is described, wherein “n” and “m” are integers independently ranging from 1 to 100. | 07-03-2014 |
20140155487 | METHOD FOR CORRECTING A LIPID IMBALANCE IN A SUBJECT - The present invention relates to methods for the treatment of a disease or condition associated with lipid imbalance using fenretinide. The invention also relates to diagnostic and screening methods based on the determination of lipid levels. | 06-05-2014 |
20140120149 | CALCIUM SULPHATE BASED COMPOSITE - A composite comprising monetite and calcium sulphate is provided. | 05-01-2014 |
20140065724 | METHOD OF PROGNOSING AND DIAGNOSING HEREDITARY SPASTIC PARAPLEGIA, MUTANT NUCLEIC ACID MOLECULES AND POLYPEPTIDES - A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG. | 03-06-2014 |
20140051760 | Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties - Hybrid molecules comprising a retinoic acid receptor agonist moiety and a histone deacetylase inhibitor (HDAC) moiety are disclosed. Hybrid molecule 3 (6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)naphthalene-2-hydroxamic acid) was proven to posses HDAC activity while maintaining RAR agonist activity. Hybrid molecule 3 and pharmaceutical compositions thereof can be used in the treatment of breast cancer, leukemia, non-small cell lung cancer, colon cancer, melanoma, ovarian cancer, renal cancer, prostate cancer and cancer of the CNS. | 02-20-2014 |
20140038914 | COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION - This invention relates to a compound of Formula 1A: | 02-06-2014 |
20140030722 | NLRP7-BASED DIAGNOSIS OF FEMALE REPRODUCTIVE CONDITIONS - Methods, reagents and kits are described for the diagnosis of a female reproductive condition such as reproductive wastage, based on the detection of an alteration in a NLRP7-encoding nucleic acid or a NLRP7 polypeptide, relative to a corresponding wild-type NLRP7-encoding nucleic acid or NLRP7 polypeptide. | 01-30-2014 |
20130203702 | HETEROCYCLYL-PYRIDINYL-BASED BIPHOSPHONIC ACID, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF - The present invention relates to novel compounds, compositions containing same and methods for inhibiting human farnesyl pyrophosphate synthase or for the treatment or prevention of disease conditions using said compounds; | 08-08-2013 |
20130184173 | BIOMARKERS FOR MULTIPLE SCLEROSIS - Biomarkers that can be used for the diagnosis and prognosis of multiple sclerosis in pediatric patients presenting with clinically isolated syndrome or acquired demyelination syndrome are described. | 07-18-2013 |
20130029989 | TOPICAL TREATMENTS FOR PAIN - The present invention relates to novel compositions and therapeutic methods for the treatment of pain, in particular neuropathic, ischemic, muscle, arthritic or multiple sclerosis pain. The compositions include a combination of an alpha2-adrenergic agonist or a nitric oxide donor combined with a phosphodiesterase (PDE) or a phosphatidic acid (PA) inhibitor, which have been found to act together synergistically to provide effective treatment for pain, especially when administered topically. | 01-31-2013 |
20130029835 | HYBRID CATALYSTS - There is provided a catalyst comprising metal nanoparticles supported on nanocrystalline cellulose and a homogeneous catalyst system comprising this catalyst colloidally suspended in a fluid. There is also provided a method of producing this catalyst and various uses thereof. | 01-31-2013 |
20130023489 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AND ENVIRONMENTALLY INDUCED HEALTH DISORDERS - Nutraceutical or pharmaceutical compositions, functional foods, extracts, dietary supplements and food/feed additives enriched in phytochemicals having antioxidant and/or anti-inflammatory activity may be derived from the skin, pith, or cortex from stem tubers of select potato cultivars, including an Onaway potato cultivar optionally complemented by a Russet Burbank, Purple Valley or Bora Valley cultivar. These cultivars and combinations thereof provide a useful antioxidant source enriched in ferulic acid, caffeic acid, chlorogenic acids, ascorbic acid, anthocyanins, and rutin, isomers or derivatives thereof having antioxidant and/or anti-inflammatory activity. | 01-24-2013 |
20120288044 | PHASE / FREQUENCY SYNTHESIS USING PERIODIC SIGMA-DELTA MODULATED BIT-STREAM TECHNIQUES - A method and a circuit are provided for providing phase or frequency synthesis using sigma-delta modulation bit-stream techniques in which data is encoded utilizing sigma-delta modulation and then digital-to-time conversion (DTC) or digital-to-frequency conversion (DFC). In some embodiments this encoded data stream is further subjected to phase or frequency domain filtering, which in some embodiments is carried out by a higher-order phase-locked loop (PLL). | 11-15-2012 |
20120280770 | TUNABLE SUBSTRATE INTEGRATED WAVEGUIDE COMPONENTS - A method and an apparatus are provided for providing a tunable substrate integrated waveguide (SIW) for which a parameter of at least some element or portion thereof may be altered or varied to alter the propagation of a signal propagating through the SIW thereby achieving a tunable SIW. In some embodiments a plurality of capacitively variably loaded transverse slots achieve the tunability for the SIW. | 11-08-2012 |
20120178690 | NOVEL NETRIN DERIVATIVES AND USES THEREOF - Netrin proteins and their receptors regulate cell and axon migration, and are implicated in tissue morphogenesis, tumorigenesis and angiogenesis. Deregulation of mechanisms that control cell motility plays a key role in tumor progression by promoting tumor cell dissemination. Unwanted neovascularization also contributes to tumor progression and metastasis and to ocular diseases which are a leading cause of blindness. Here, we describe novel netrin-derived polypeptides and fragments or derivatives thereof that selectively inhibit cell growth, migration or branching. Methods and compositions for the treatment and prevention of conditions involving cell migration or neovascularization, such as cancer and ocular disease, are also provided. | 07-12-2012 |
20120129772 | SOLUBLE IGF RECEPTORS AS ANTI-ANGIOGENIC AGENTS - There is disclosed a method of inhibiting angiogenesis in a patient having an angiogenic associated disorder comprising administering to said patient a therapeutically effective amount of a soluble IGF-IR protein. The use of such soluble IGF-IR protein for inhibiting angiogenesis in a patient is also disclosed. | 05-24-2012 |
20120087919 | METHOD FOR TREATING DIABETES - Fusion proteins binding specifically to cell types of the islets of Langerhans and delivering therapeutic or prophylactic agents are provided herein, as well as compositions thereof. Methods for treating or preventing diseases related to the pancreas such as diabetes are also disclosed. The therapeutic or prophylactic agents include Nemo-binding domain peptides and other inhibitors of NF-kB activation. | 04-12-2012 |
20120079614 | CD109 POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF SKIN CELLS - The invention concerns compounds, compositions and methods for the treatment of skin cells. Described herein are CD109 polypeptides and uses thereof for the in vivo treatment of various skin disorders, including skin fibrosis, skin scarring, wound healing and psoriasis. | 03-29-2012 |
20120070848 | TUMOR CELL-DERIVED MICROVESICLES - The present invention relates to a method for diagnosis of cancer and for monitoring the progression of cancer and/or the therapeutic efficacy of an anti-cancer treatment in a sample of a subject by detecting oncogenic proteins in microvesicles, and to the use of an agent blocking exchange of microvesicles for treating cancer. | 03-22-2012 |
20120021936 | BIOMARKERS FOR DENGUE - The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying dengue status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with dengue or not infected with dengue. The biomarkers can be detected by SELDI mass spectrometry. | 01-26-2012 |
20110293045 | METHODS AND SYSTEMS FOR IMPROVING ITERATIVE SIGNAL PROCESSING - A method for iteratively decoding a set of encoded samples received from a transmission channel is provided. A data signal indicative of a noise level of the transmission channel is received. A scaling factor is then determined in dependence upon the data signal and the encoded samples are scaled using the scaling factor. The scaled encoded samples are then iteratively decoded. Furthermore, a method for initializing edge memories is provided. During an initialization phase initialization symbols are received from a node of a logic circuitry and stored in a respective edge memory. The initialization phase is terminated when the received symbols occupy a predetermined portion of the edge memory. An iterative process is executed using the logic circuitry storing output symbols received from the node in the edge memory and a symbol is retrieved from the edge memory and provided as output symbol of the node. Yet further an architecture for a high degree variable node is provided. A plurality of sub nodes forms a variable node for performing an equality function in an iterative decoding process. Internal memory is interposed between the sub nodes such that the internal memory is connected to an output port of a respective sub node and to an input port of a following sub node, the internal memory for providing a chosen symbol if a respective sub node is in a hold state, and wherein at least two sub nodes share a same internal memory. | 12-01-2011 |
20110152210 | POLYPHENOL COMPOUNDS FOR INHIBITING PROTEASOME AND USES THEREOF - Synthetic polyphenolic compounds of formula (I), their modes of synthesis, and pharmaceutical compositions thereof are provided herein. Use of the compounds and compositions described herein for inhibiting proteasomal activity and for treating cancer is also provided. | 06-23-2011 |
20110027930 | Low Temperature Wafer Level Processing for MEMS Devices - Microelectromechanical systems (MEMS) are small integrated devices or systems that combine electrical and mechanical components. It would be beneficial for such MEMS devices to be integrated with silicon CMOS electronics and packaged in controlled environments and support industry standard mounting interconnections such as solder bump through the provisioning of through-wafer via-based electrical interconnections. However, the fragile nature of the MEMS devices, the requirement for vacuum, hermetic sealing, and stresses placed on metallization membranes are not present in packaging conventional CMOS electronics. Accordingly there is provided a means of reinforcing the through-wafer vias for such integrated MEMS-CMOS circuits by in filling a predetermined portion of the through-wafer electrical vias with low temperature deposited ceramic materials which are deposited at temperatures below 350° C., and potentially to below 250° C., thereby allowing the re-inforcing ceramic to be deposited after fabrication of the CMOS electronics. | 02-03-2011 |
20100308982 | FLOOR-BASED HAPTIC COMMUNICATION SYSTEM - The present relates to a system for providing vibration feedback to at least one foot. The system comprises at least one rigid surface for receiving the at least one foot, one vibrotactile actuator for each of the at least one rigid surface, and a suspension mechanism. The vibrotactile actuator is installed underneath the corresponding rigid surface and provides vibration feedback there through. The suspension mechanism supports the at least one rigid surface. | 12-09-2010 |
20100298163 | MICROFLUIDIC MICROARRAY SYSTEM AND METHOD FOR THE MULTIPLEXED ANALYSIS OF BIOMOLECULES - A microfluidic system for fluid transfer to a microarray includes a liquid transfer needle having a fluid conduit therein within which is defined a withholding pressure P | 11-25-2010 |
20100255514 | TUMOR CELL-DERIVED MICROVESICLES - The present invention relates to a method for diagnosis of cancer and for monitoring the progression of cancer and/or the therapeutic efficacy of an anti-cancer treatment in a sample of a subject by detecting oncogenic and cancer related proteins in microvesicles, and to the use of an agent blocking exchange of microvesicles for treating cancer. | 10-07-2010 |
20100191130 | METHOD FOR DETECTING PATHOLOGIES USING CARDIAC ACTIVITY DATA - The invention relates to a method for determining a pathology in a subject, said method comprising: a) correlating N-N intervals with rate dependent fluctuations of electrocardiographic parameters derived from an electrocardiogram (ECG) of said subject or other recordings reflecting cardiac activity of said subject to derive electrocardiographic parameters correlation values, wherein said pathology is determined based on said correlation values. | 07-29-2010 |
20100114388 | METHOD AND SYSTEM FOR CONTROLLING A DOUBLY-FED INDUCTION MACHINE - The present invention relates to a method and system for controlling a doubly-fed induction machine. In operation a rotor current vector is processed with a rotor position estimate vector. A scalar error quantity is the determined in dependence upon a stator current vector and the processed rotor current vector. The scalar error quantity is integrated and an estimate of the rotor angular frequency is determined in dependence upon the integrated scalar error quantity. To obtain a rotor position estimate, the estimate of the rotor angular frequency is integrated and a rotor position estimate vector is determined in dependence upon the rotor position estimate. The rotor position estimate vector is then provided for processing the rotor current vector. As output signals a signal indicative of the rotor position estimate vector and a signal indicative of the estimate of the rotor angular frequency are provided for controlling the doubly-fed induction machine. | 05-06-2010 |
20100111981 | SYNTHETIC MONODISPERSE HEMOZOIN CRYSTALS PREPARATION AND USES THEREOF - A synthetic monodisperse hemozoin crystals preparation, compositions and methods of preparation thereof, are described. Also described are uses thereof, including use as an adjuvant, use in an immunogenic or vaccine composition, use for enhancing or inducing immunogenicity, and corresponding prevention or treatment of disease or infection. | 05-06-2010 |
20100017676 | DECODING OF LINEAR CODES WITH PARITY CHECK MATRIX - A decoding method and system for stochastic decoding of linear codes with the parity check matrix comprising elements of a Galois field is provided. Each encoded sample of a set of encoded samples is first scaled by a scaling factor proportional to a noise level of the set of encoded samples. Each of the scaled encoded samples is then converted into a corresponding probability. For each probability a corresponding probability message is the generated by encoding each probability as a sequence of symbols or bits. Each probability message is then provided to a respective variable node of a logic circuitry for stochastic decoding. The logic circuitry represents a factor graph of the parity check matrix of the linear code. Using the logic circuitry each probability message is passed through the factor graph by performing for each received symbol at the variable nodes the equality function, at the permutation nodes one of multiplication and division, and at the parity check nodes the parity check function, wherein each of the variable nodes provides an output symbol in dependence upon each received symbol. | 01-21-2010 |
20090220240 | HIGH-SPEED BANDPASS SERIAL DATA LINK - The present invention relates to a method and system for high-speed bandpass serial data communication. A driver receives at least one data signal and generates a bandpass data signal for transmission through a bandpass waveguide interconnect. The bandpass data signal is launched into the bandpass waveguide interconnect using a first adaptor and extracted therefrom after transmission using a second adaptor. A receiver connected to the second adaptor recovers the at least one data signal from the extracted bandpass data signal. A dispersion compensation circuit receives one of the at least one data signal and the bandpass data signal and information indicative of a phase response of the bandpass waveguide interconnect and dispersion compensates the one of the at least one data signal and the bandpass data signal by compensating the phase response of the bandpass waveguide interconnect. | 09-03-2009 |
20090160040 | LOW TEMPERATURE CERAMIC MICROELECTROMECHANICAL STRUCTURES - A method of providing microelectromechanical structures (MEMS) that are compatible with silicon CMOS electronics is provided. The method provides for processing and manufacturing is steps limiting a maximum exposure of an integrated circuit upon which the MEMS is manufactured during MEMS manufacturing to below a temperature wherein CMOS circuitry is adversely affected, for example below 400° C., and sometimes to below 300° C. or 250° C., thereby allowing direct manufacturing of the MEMS devices onto electronic integrated circuits, such as Si CMOS circuits. | 06-25-2009 |
20090100313 | METHODS AND APPARATUSES OF MATHEMATICAL PROCESSING - Disclosed is a pipelined iterative process and system. Data is received at an input port and is processed in a symbolwise fashion. Processing of each symbol is performed other than relying on completing the processing of an immediately preceding symbol such that operation of the system or process is independent of an order of the input symbols. | 04-16-2009 |
20080294970 | Method for implementing stochastic equality nodes - The present invention relates to a decoding method and system for stochastic decoding of linear block codes with parity check matrix. Each encoded sample of a set of encoded samples is converted into a corresponding probability. For each probability a corresponding probability message is the generated by encoding each probability as a sequence of digital symbols. Each probability message is then provided to a respective node of a logic circuitry for stochastic decoding. The logic circuitry represents a factor graph of the parity check matrix of the linear block code. Using the logic circuitry each probability message is processed for determining an estimated sequence of information symbols. If an equality node is in a hold state a chosen symbol is provided from a corresponding memory which is updated by storing output symbols from the equality node when the same is in a state other than a hold state. | 11-27-2008 |
20080269341 | Method for Correcting a Lipid Imbalance in a Subject - The present invention relates to methods for the treatment of a disease or condition associated with lipid imbalance, comprising (a) decreasing arachidonic acid (AA) levels, (b) increasing docosahexaenoic acid (DHA) levels, (c) increasing DHA/AA ratio or (d) any combination of (a)-(c) in a subject using fenretinide. The invention also relates to diagnostic and screening methods based on the determination of lipid levels. | 10-30-2008 |
20080256343 | Convergence determination and scaling factor estimation based on sensed switching activity or measured power consumption - A method and system for determining convergence of iterative processes and estimating a scaling factor in decoding processes based on switching activity of the logic circuitry are provided. During execution of an iterative process using logic circuitry comprising logic gates switching activity of a plurality of the logic gates is sensed to determine switching data indicative of a total switching activity of the plurality of the logic gates. The iterative process is iterated using the logic circuitry until convergence is indicated by the switching data. Similarly, a scaling factor for use in decoding processes is determined based on the switching data. | 10-16-2008 |